Skip to main content

Oncology

Leukemia, Oncology
Promising Drugs in the Pipeline for Leukemia and Myelodysplastic Syndromes
Wayne Kuznar
Read More
Lung Cancer, Oncology
Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer
Read More
Breast Cancer, Oncology
New Data Confirm Benefits of 10 Years Tamoxifen versus 5 Years in Patients with ER-Positive Breast Cancer
Wayne Kuznar
Read More
Lung Cancer, Oncology
Current Treatment of Advanced NSCLC Requires Testing for Driver Mutations
Wayne Kuznar
Read More
Lung Cancer, Oncology
Afatinib Doubles Progression-Free Survival Compared with Chemotherapy in Patients with Lung Cancer
Wayne Kuznar
Read More
Lung Cancer, Oncology
Dabrafenib Shows Promising Results in Patients with Stage IV NSCLC
Wayne Kuznar
Read More
Melanoma, Oncology
Immunotherapies Take Center Stage in Melanoma
Audrey Andrews
Read More
Leukemia, Oncology
Initial Choice of TKI in Patients with CML Probably Not Important
Mark Knight
Read More
Multiple Myeloma, Oncology
Oral Proteasome Inhibitor MLN9708 a News Maker at ASH 2012
Caroline Helwick
Read More
Multiple Myeloma, Oncology
Four-Drug Induction and 2-Drug Maintenance Boost Overall Survival in Patients with Newly Diagnosed Myeloma
Audrey Andrews
Read More
Page 22 of 27
Results 211 - 220 of 262